John E Gerich
Overview
Explore the profile of John E Gerich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alsahli M, Gerich J
Diabetes Res Clin Pract
. 2017 Sep;
133:1-9.
PMID: 28866383
The kidney plays an important role in glucose homeostasis via gluconeogenesis, glucose utilization, and glucose reabsorption from the renal glomerular filtrate. After an overnight fast, 20-25% of glucose released into...
2.
Alsahli M, Gerich J
J Clin Med
. 2015 Aug;
4(5):948-64.
PMID: 26239457
This article summarizes our current knowledge of the epidemiology, pathogenesis, and morbidity of hypoglycemia in patients with diabetic kidney disease and reviews therapeutic limitations in this situation.
3.
Alsahli M, Gerich J
Mayo Clin Proc
. 2014 Oct;
89(11):1564-71.
PMID: 25305751
Hypoglycemia is a major problem associated with substantial morbidity and mortality in patients with diabetes and is often a major barrier to achieving optimal glycemic control. Chronic kidney disease not...
4.
Hasan F, Alsahli M, Gerich J
Diabetes Res Clin Pract
. 2014 Apr;
104(3):297-322.
PMID: 24735709
The kidney plays an important role in glucose homeostasis via its production, utilization, and, most importantly, reabsorption of glucose from glomerular filtrate which is largely mediated via the sodium glucose...
5.
Alsahli M, Gerich J
Endocrinol Metab Clin North Am
. 2013 Nov;
42(4):657-76.
PMID: 24286945
Hypoglycemia remains a common problem for patients with diabetes and is associated with substantial morbidity and mortality. This article summarizes our current knowledge of the epidemiology, pathogenesis, risk factors, and...
6.
Rosenstock J, Raccah D, Koranyi L, Maffei L, Boka G, Miossec P, et al.
Diabetes Care
. 2013 May;
36(10):2945-51.
PMID: 23698396
Objective: To compare efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled with metformin. Research Design And Methods: Adults with diabetes inadequately...
7.
Fonseca V, Alvarado-Ruiz R, Raccah D, Boka G, Miossec P, Gerich J
Diabetes Care
. 2012 Mar;
35(6):1225-31.
PMID: 22432104
Objective: To assess efficacy and safety of lixisenatide monotherapy in type 2 diabetes. Research Design And Methods: Randomized, double-blind, 12-week study of 361 patients not on glucose-lowering therapy (HbA(1c) 7-10%)...
8.
Gerich J, Bastien A
Expert Rev Clin Pharmacol
. 2011 Nov;
4(6):669-83.
PMID: 22111852
Dapagliflozin is a highly selective sodium-glucose co-transporter 2 inhibitor developed for the treatment of Type 2 diabetes mellitus. Its inhibition of sodium-glucose co-transporter 2 blocks glucose reabsorption in the proximal...
9.
Aryangat A, Gerich J
Vasc Health Risk Manag
. 2010 May;
6:145-55.
PMID: 20448799
Hyperglycemia is a major risk factor for both the microvascular and macrovascular complications in patients with type 2 diabetes. This review summarizes the cardiovascular results of large outcomes trials in...
10.
Samsom M, Bharucha A, Gerich J, Herrmann K, Limmer J, Linke R, et al.
Diabetes Metab Res Rev
. 2009 Jul;
25(6):502-14.
PMID: 19610128
It is long known that both type 1 and type 2 diabetes can be associated with changes in gastric emptying; a number of publications have linked diabetes to delayed gastric...